87 related articles for article (PubMed ID: 22968973)
1. Significant differences in coeliac immunotoxicity of barley varieties.
Comino I; Real A; Gil-Humanes J; Pistón F; de Lorenzo L; Moreno Mde L; López-Casado MÁ; Lorite P; Cebolla A; Torres MI; Barro F; Sousa C
Mol Nutr Food Res; 2012 Nov; 56(11):1697-707. PubMed ID: 22968973
[TBL] [Abstract][Full Text] [Related]
2. Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease.
Comino I; Real A; de Lorenzo L; Cornell H; López-Casado MÁ; Barro F; Lorite P; Torres MI; Cebolla A; Sousa C
Gut; 2011 Jul; 60(7):915-22. PubMed ID: 21317420
[TBL] [Abstract][Full Text] [Related]
3. Coeliac disease: immunogenicity studies of barley hordein and rye secalin-derived peptides.
Wahab WA; Šuligoj T; Ellis J; Côrtez-Real B; Ciclitira PJ
Int J Exp Pathol; 2016 Aug; 97(4):303-309. PubMed ID: 27659035
[TBL] [Abstract][Full Text] [Related]
4. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa.
Bracken SC; Kilmartin C; Wieser H; Jackson J; Feighery C
Aliment Pharmacol Ther; 2006 May; 23(9):1307-14. PubMed ID: 16629935
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the T-cell response to hordeins in coeliac disease can develop barley with reduced immunotoxicity.
Tanner GJ; Howitt CA; Forrester RI; Campbell PM; Tye-Din JA; Anderson RP
Aliment Pharmacol Ther; 2010 Nov; 32(9):1184-91. PubMed ID: 21039679
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease.
Tye-Din JA; Stewart JA; Dromey JA; Beissbarth T; van Heel DA; Tatham A; Henderson K; Mannering SI; Gianfrani C; Jewell DP; Hill AV; McCluskey J; Rossjohn J; Anderson RP
Sci Transl Med; 2010 Jul; 2(41):41ra51. PubMed ID: 20650871
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of clinical and immune reactivity to barley and rye ingestion in children with coeliac disease.
Hardy MY; Russell AK; Pizzey C; Jones CM; Watson KA; La Gruta NL; Cameron DJ; Tye-Din JA
Gut; 2020 May; 69(5):830-840. PubMed ID: 31462555
[TBL] [Abstract][Full Text] [Related]
8. Avenins from different cultivars of oats elicit response by coeliac peripheral lymphocytes.
Silano M; Di Benedetto R; Maialetti F; De Vincenzi A; Calcaterra R; Cornell HJ; De Vincenzi M
Scand J Gastroenterol; 2007 Nov; 42(11):1302-5. PubMed ID: 17852883
[TBL] [Abstract][Full Text] [Related]
9. Molecular and immunological characterization of gluten proteins isolated from oat cultivars that differ in toxicity for celiac disease.
Real A; Comino I; de Lorenzo L; Merchán F; Gil-Humanes J; Giménez MJ; López-Casado MÁ; Torres MI; Cebolla Á; Sousa C; Barro F; Pistón F
PLoS One; 2012; 7(12):e48365. PubMed ID: 23284616
[TBL] [Abstract][Full Text] [Related]
10. The effects of reduced gluten barley diet on humoral and cell-mediated systemic immune responses of gluten-sensitive rhesus macaques.
Sestak K; Thwin H; Dufour J; Aye PP; Liu DX; Moehs CP
Nutrients; 2015 Mar; 7(3):1657-71. PubMed ID: 25756783
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of the presence of coeliac-activating gliadin-like epitopes in malted barley.
Ellis HJ; Doyle AP; Day P; Wieser H; Ciclitira PJ
Int Arch Allergy Immunol; 1994 Jul; 104(3):308-10. PubMed ID: 7518270
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of two oat varieties, in relation to their safety for celiac patients.
Maglio M; Mazzarella G; Barone MV; Gianfrani C; Pogna N; Gazza L; Stefanile R; Camarca A; Colicchio B; Nanayakkara M; Miele E; Iaquinto G; Giardullo N; Maurano F; Santoro P; Troncone R; Auricchio S
Scand J Gastroenterol; 2011 Oct; 46(10):1194-205. PubMed ID: 21843037
[TBL] [Abstract][Full Text] [Related]
13. Detection and quantitation of immunogenic epitopes related to celiac disease in historical and modern hard red spring wheat cultivars.
Malalgoda M; Meinhardt SW; Simsek S
Food Chem; 2018 Oct; 264():101-107. PubMed ID: 29853353
[TBL] [Abstract][Full Text] [Related]
14. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients.
Spaenij-Dekking L; Kooy-Winkelaar Y; van Veelen P; Drijfhout JW; Jonker H; van Soest L; Smulders MJ; Bosch D; Gilissen LJ; Koning F
Gastroenterology; 2005 Sep; 129(3):797-806. PubMed ID: 16143119
[TBL] [Abstract][Full Text] [Related]
15. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.
Pizzuti D; Buda A; D'Odorico A; D'Incà R; Chiarelli S; Curioni A; Martines D
Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124
[TBL] [Abstract][Full Text] [Related]
16. No induction of anti-avenin IgA by oats in adult, diet-treated coeliac disease.
Guttormsen V; Løvik A; Bye A; Bratlie J; Mørkrid L; Lundin KE
Scand J Gastroenterol; 2008; 43(2):161-5. PubMed ID: 18224563
[TBL] [Abstract][Full Text] [Related]
17. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
[TBL] [Abstract][Full Text] [Related]
18. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.
Devery JM; La Brooy JT; Krillis S; Davidson G; Skerritt JH
Clin Exp Immunol; 1989 Jun; 76(3):384-90. PubMed ID: 2752594
[TBL] [Abstract][Full Text] [Related]
19. Ingestion of oats and barley in patients with celiac disease mobilizes cross-reactive T cells activated by avenin peptides and immuno-dominant hordein peptides.
Hardy MY; Tye-Din JA; Stewart JA; Schmitz F; Dudek NL; Hanchapola I; Purcell AW; Anderson RP
J Autoimmun; 2015 Jan; 56():56-65. PubMed ID: 25457306
[TBL] [Abstract][Full Text] [Related]
20. The use of extended amino acid motifs for focussing on toxic peptides in coeliac disease.
McLachlan A; Cullis PG; Cornell HJ
J Biochem Mol Biol Biophys; 2002 Oct; 6(5):319-24. PubMed ID: 12385967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
